Scarica l'app Stockscreener
4.92
5.35%
0.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.67
Aprire:
$4.66
Volume 24 ore:
2.40M
Relative Volume:
1.50
Capitalizzazione di mercato:
$1.00B
Reddito:
-
Utile/perdita netta:
$-54.70M
Rapporto P/E:
-14.91
EPS:
-0.33
Flusso di cassa netto:
$-51.36M
1 W Prestazione:
+14.42%
1M Prestazione:
+16.31%
6M Prestazione:
+69.07%
1 anno Prestazione:
+51.85%
Intervallo 1D:
$4.59
$4.935
Intervallo di 1 settimana:
$4.145
$4.935
Portata 52W:
$1.89
$4.935
Savara Inc Stock (SVRA) Company Profile
Nome
Savara Inc
Settore
Industria
Telefono
51285113796
Indirizzo
6836 BEE CAVE ROAD, AUSTIN, TX
Confronta SVRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
4.92 | 950.19M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-08-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | Iniziato | Wells Fargo | Overweight |
| 2024-11-13 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-02-15 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-11-07 | Iniziato | Guggenheim | Buy |
| 2023-05-16 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-03-31 | Downgrade | Jefferies | Buy → Hold |
| 2021-03-16 | Iniziato | Piper Sandler | Overweight |
| 2021-03-15 | Iniziato | Oppenheimer | Outperform |
| 2019-06-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-13 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | Ripresa | ROTH Capital | Neutral |
| 2018-01-03 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-09-27 | Ripresa | ROTH Capital | Buy |
| 2017-09-22 | Iniziato | Jefferies | Buy |
| 2017-09-11 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Savara Inc Borsa (SVRA) Ultime notizie
Savara Announces Participation in Upcoming December 2025 Investor Healthcare Conferences - BioSpace
Applying sector rotation models to Savara Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
Savara Announces Participation in Upcoming Investor Healthcare Conferences - Bluefield Daily Telegraph
Global NTM Infections Pipeline Poised for Growth as Breakthrough Therapies Advance Toward Late-Stage Development, states DelveInsight - The Globe and Mail
Savara (NASDAQ:SVRA) Shares Up 7.3%Still a Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Savara Inc. (SVRA) And Encourages Stockholders to Connect - ACCESS Newswire
Adversity is less terrifying than hope: Savara Inc (SVRA) - Setenews
How Savara Inc. stock compares to industry benchmarksOptions Play & Weekly Breakout Watchlists - newser.com
Savara (NASDAQ:SVRA) Reaches New 52-Week HighTime to Buy? - MarketBeat
Pattern recognition hints at Savara Inc. upsideWeekly Trade Review & Long-Term Capital Growth Ideas - newser.com
Investigation announced for Long-Term Investors in shares of Savara Inc. (NASDAQ: SVRA) - openPR.com
Will Savara Inc. stock continue dividend increasesWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - newser.com
What makes Markel Group Inc. stock price move sharply - newser.com
Visual analytics tools that track Savara Inc. performance2025 Price Action Summary & Fast Entry and Exit Trade Plans - newser.com
Full technical analysis of Savara Inc. stock2025 Risk Factors & Weekly Setup with ROI Potential - newser.com
Is Savara Inc. stock trading at a premium valuationIPO Watch & Free Technical Pattern Based Buy Signals - newser.com
Is Savara Inc. (YB4P) stock in buy zone after pullbackPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Volatility clustering patterns for Savara Inc.Market Volume Report & Detailed Earnings Play Strategies - newser.com
Savara Inc stock hits 52-week high at 4.51 USD By Investing.com - Investing.com Nigeria
Savara Inc. stock momentum explainedWeekly Trading Summary & Daily Profit Focused Stock Screening - newser.com
Short interest data insights for Savara Inc.Trade Volume Summary & Fast Entry High Yield Tips - newser.com
Savara Inc. $SVRA Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Multi asset correlation models including Savara Inc.Earnings Risk Summary & Weekly Return Optimization Plans - newser.com
Will Savara Inc. (YB4P) stock boost dividends furtherWeekly Risk Summary & Long-Term Capital Growth Ideas - newser.com
Is Savara Inc. stock attractive for income investorsPortfolio Performance Summary & Weekly Watchlist of Top Performers - newser.com
HC Wainwright Has Positive Outlook of Savara FY2029 Earnings - MarketBeat
Savara Inc. Reports Q3 2025 Financial Results - TipRanks
Lifesci Capital Analysts Raise Earnings Estimates for Savara - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Savara Inc. (SVRA) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Is Savara Inc. (YB4P) stock supported by free cash flowTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
What Fibonacci levels say about Savara Inc. rebound2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
2025-11-16 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Savara Inc. (SVRA) and Encourages Stockholders to Learn More About the Investigation | NDAQ:SVRA | Press Release - Stockhouse
Savara Stock: A High-Risk Opportunity (NASDAQ:SVRA) - Seeking Alpha
Oppenheimer Reaffirms Their Buy Rating on Savara (SVRA) - The Globe and Mail
Why Savara Inc. stock could outperform in 2025Market Movement Recap & Free Technical Pattern Based Buy Signals - newser.com
Savara (NASDAQ:SVRA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Savara Inc Azioni (SVRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):